Connection

Yuki Kageyama to Gene Expression Regulation, Neoplastic

This is a "connection" page, showing publications Yuki Kageyama has written about Gene Expression Regulation, Neoplastic.
  1. Expression of CD25 fluctuates in the leukemia-initiating cell population of CD25-positive AML. PLoS One. 2018; 13(12):e0209295.
    View in: PubMed
    Score: 0.085
  2. Expression failure of the notch signaling system is associated with the pathogenesis of testicular germ cell tumor. Tumour Biol. 2004 May-Jun; 25(3):99-105.
    View in: PubMed
    Score: 0.031
  3. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation. Exp Cell Res. 2002 Jun 10; 276(2):194-200.
    View in: PubMed
    Score: 0.027
  4. Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma. Cancer. 2001 Apr 15; 91(8):1429-36.
    View in: PubMed
    Score: 0.025
  5. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):6012-7.
    View in: PubMed
    Score: 0.009
  6. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids. Mol Cell Endocrinol. 2004 Oct 29; 226(1-2):11-7.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.